Cite
HARVARD Citation
Baak, L. et al. (2022). Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study. Lancet neurology. 21 (6), pp. 528-536. [Online].